Integrins and integrin-associated molecules: Targets for the development of antimetastasic therapies;Integrinas y moléculas asociadas a integrinas: Blancos para el desarrollo de terapias antimetastásicas

Revista de Investigacion Clinica

Volumn 51, Issue 3, 1999, Pages 183-193

  Velasco Velázquez, Marco Antonio ^a   Molina Guarneros, Juan Arcadio ^a   Mendoza Patiño, Nicandro ^a   López G, José Sullivan ^b   Mandoki, Juan José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

Adhesion; Disintegrins; Integrins; Metastasis; RGD

Indexed keywords

DISINTEGRIN; INTEGRIN;

ANIMAL; BIOLOGICAL MODEL; CANCER INVASION; CELL ADHESION; HUMAN; METASTASIS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; DISINTEGRINS; HUMANS; INTEGRINS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION;

EID: 0142073129     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
2. Imhof BA, Dunon D. Leukocyte migration and cell adhesion. Adv Immunol 1995; 58: 345-417.
3. D'Souza SE, Haas TA, Piotrowicz RS, Byers-Ward V, McGrath DE, Soule HR et al. Ligand and cation binding are dual function of a discrete segment of the integrin β3 subunit; cation displacement is involved in ligand binding. Cell 1994; 79: 659-67.
4. Stuiver I, Ruggeri Z, Smith JW. Divalent cations regulate the organization of integrins αvβ3 and αvβ5 on the cell surface. J Cell Physiol 1996; 168: 521-31.
5. Ruoslahti E. RGD and other related sequences for integrins. Ann Rev Cell Dev Biol 1996; 12: 697-715.
6. Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Ann Rev Cell Dev Biol 1996; 12: 463-519.
7. LaFlamme S, Auer KL. Integrin signaling. Sem Cancer Biol 1996; 7: 111-8.
8. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995; 268: 233-9.
9. Turner CE. Paxillin: a cytoeskeletal target for tyrosin kinases. BioEssays 1994; 16: 47-52.
10. Schaller MD, Otey CA, Hildebrand JD, Parsons JT. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmatic domains. J Cell Biol 1995; 130: 1181-7.
11. Tachibana K, Sato T, D'Avirro N, Morimoto C. Direct-association of pp125 FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J Exp Med 1995; 182: 1089-99.
12. SRC. Mol Cell Biol 1995; 14: 1680-8.
13. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role of Src-family kinases. Mol Cell Biol 1995; 15: 954-63.
14. Yamada KM, Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr Op Cell Biol 1995; 7: 681-9.
15. Schlaepfer DD, Hanks SK, Hunter T, Van der Geer P. Integrin mediated signal transduction linked to ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786-91.
16. Hanks SK, Polte TR. Signaling trough focal adhesion kinase. BioEssays 1997; 19: 137-45.
17. Miyamoto S, Teramoto H, Gutkind JS, Yamada K. Integrins can collaborate with growth factors for phosporylation of receptor tyrosin kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors. J Cell Biol 1996; 135: 1633-42.
18. Helmer ME, Mannion BA, Berditchvski F. Association of TM4SF proteins with integrins: Relevance to cancer. Biochim Biophys Acta 1996; 1287: 67-71.
19. Serini G, Trusolino L, Saggiorato E, Cremona O, De Rossi M, Angeli A et al. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J Natl Cancer Inst 1996; 88: 442-9.
20. Seftor REB, Seftor EA, Gehlsen WG, Stetler-Stevenson PD, Brown E, Ruoslahti E, Hendrix M. Role of the alphav/beta3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 1992; 89: 1557-61.
21. Huhtala P, Humpries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteins gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995; 129: 867-79.
22. Guadano TM, Ohtsubo, Roberts JM, Assoian RK. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 1993; 262: 1572-5.
23. Kuzumaki T, Matsuda A, Kikukatsu Y, Ishikawa K. Cell adhesion to substratum and activation of tyrosin kinases are essentially required for G1/S phase transition in BALB/c 3T3 fibroblasts. Biochim Biophys Acta 1995; 1310: 185-92.
24. Fang F, Gertraud O, Nobumoto N, Hunter T, Ruoslahti E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 1996; 271: 499-502.
25. Firsh SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-26.
26. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994; 77: 477-8.
27. Firsh SM, Vuori K, Ruoslahti E, Chan-Hui P. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134: 793-9.
28. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanism of metastasis. Cancer 1997; 80 (suppl): 1529-37.
29. Ruoslahti E, Giancotti FG. Integrins and tumor cell dissemination. Cancer Cells 1989; 1: 119-26.
30. Senger DR, Claffey KP, Benes JE, Perruzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation trough alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 1997; 94: 13612-17.
31. Van Waes C. Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing. Head Neck 1995; 17: 140-7.
32. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 1157-64.
33. Brooks PC, Stromblad S, Kieme R, Sarkar FH, Cheresh DA. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995; 96: 1815-22.
34. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996; 8: 724-30.
35. Albelda S. Biology of disease. Role of integrins and other adhesion molecules in tumor progression and metastasis. Lab Invest 1993; 68: 4-17.
36. Mariani-Costantini R, Falcioni R, Battista P, Zupi G, Kennel SJ, Colasante A et al. Integrin α6β4 expression in human lung cancer as monitored by specific monoclonal antibodies. Cancer Res 1990; 50: 6107-12.
37. Carico E, French D, Bucci B, Falcioni R, Vecchione A, Mariani-Costantini R. Integrin β4 expression in the neoplastic progression of cervical epithelium. Gynecol-Oncol 1993; 49: 61-3.
38. Van Waes C, Surh DM, Chen Z, Kirby M, Rhim JS, Brager S et al. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 1995; 55: 5434-44.
39. Chao C, Lotz MM, Clarke AC, Mercurio AM. A function for the integrin α6β4 in the invasive properties of colorectal carcinoma cells. Cancer Res 1996; 56: 4811-9.
40. Imhof BA, Piali L, Gisler RH, Dunon D. Involvement of α6 and αv integrins in metastasis. Curr Top Microbiol Immunol 1996; 213: 195-203.
41. Falcioni R, Cimino L, Perrotti D, Rizzo MG, Sacchi A. α6/β4 integrin in lung carcinoma in cancer and inflammation. In: Epenetos A, Pignatelli M (eds). Cell adhesion molecules in cancer and inflammation. Switzerland: Harwood Academic Publishers, 1995: 45-58.
42. Albeda MA, Mette SA, Elder DE, Stewart RM, Damjanovich L, Herlyn M et al. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 1990; 50: 6757-74.
43. Filardo EJ, Brooks PC, Deming SL, Damsky C, Cheresh DA. Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J Cell Biol 1995; 130: 441-50.
44. Nip J, Shibata H, Loskutoff DJ, Cheresh DA, Brodt P. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin. J Clin Invest 1992; 90: 1406-13.
45. Nierodzik ML, Klepfish A, Karpatkin S. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 1995; 74: 282-90
46. Dardik R, Kaufmann Y, Savion N, Rosenberg N, Shenkman B. Varon D. Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GP IIb-IIIa and tumor cell alpha v integrins. Int J Cancer 1997; 70: 201-7.
47. Mitjans F, Sander D, Adán J, Sutter A, Martinez JM, Jäggle CS et al. An anti-alpha v integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci 1995; 108: 2825-38.
48. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989; 246: 1303-6.
49. Albeda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4: 2868-80.
50. Ruiz P, Dunon D, Sonnenberg A, Imhof BA. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. Cell Adh Comm 1993; 1: 67-87.
51. Plantefaber LC, Hynes RO. Changes in integrin receptors on oncogenically transformed cells. Cell 1989; 56: 281-90.
52. Schreiner C, Fisher M, Hussein S, Juliano RL. Increased tumorigenicity of fibronectin receptor deficient chinese hamster ovary cell variants. Cancer Res 1991; 51: 1738-40.
53. Giancotti FG, Ruoslahti E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990; 60: 849-59.
54. Varner JA, Emerson DA, Juliano RL. Integrin α5β1 expression negatively regulates cell growth: reversal attachment to fibronectin. Mol Biol Cell 1995; 6: 725-40.
55. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The alpha5 beta 1 integrin supports survival of cells on fibronectin and up regulates Bcl-2 expression. Proc Natl Acad Sci USA 1995; 92: 6161-5.
56. Bordeau N, Sympson CJ, Werb Z, Bisell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-3.
57. Bates RC, Buret A, van Helden DF, Horton MA, Burns CF. Apoptosis induced by inhibition of intercellular contacts. J Cell Biol 1994; 125: 403-15.
58. Montgomery AM, Reisfeld RA, Cheresh DA. Integrin αvβ3 rescues melanoma cells from apoptosis in three dimensional dermal collagen. Proc Natl Acad Sci USA 1994; 91: 8856-60.
59. Gilmore AP, Romer LH. Inhibition of FAK signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 1996; 7: 1209-24.
60. Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993; 342: 1024-5.
61. Xu L, Owens LV, Sturge CC, Yang X, Liu ET, Craven RJ, et al. Attenuation of the expression of focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Diff 1996; 7: 413-8.
62. Romer LH, McLean N, Turner CE, Burridge K. Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells. Mol Biol Cell 1994; 5: 349-61.
63. Dong JT, Lamb PW, Rinker Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11 p11.2. Science 1995; 268: 884-6.
64. Miyake M, Nakano K, Ieki Y, Adachi M, Huang CL, Itoi S et al. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 1995; 55: 4127-31.
65. Higashiyama M, Taki T, Ieki Y, Adachi M, Huang CL, Koh T et al. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 1995; 55: 6040-4.
66. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993; 177: 1231-7.
67. Radford KJ, Mallesch J, Hersey P. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 1995; 62: 631-5.
68. Pasqualini R, Bordoulous S, Koivunen E, Woods VL, Ruoslahti E. A polymeric form of fibronectin has antimetastasic effects against multiple tumor types. Nature Med 1996; 2: 1197-203.
69. Ruoslahti E. Integrins as signaling molecules and targets for tumor therapy. Kidney Int 1997; 51: 1413-7.
70. Humpries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233: 467-70.
71. Saiki I, Murata J, Iida J, Sakurai T, Nishi N, Matsuno K et al. Antimetastasic effects of synthetic peptides containing repeated structures of cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YICSR) sequences. Br J Cancer 1989; 60: 722-8.
72. Saiki I, Iida J, Murata J, Ogawa R, Nishi N, Sugimura K et al. Inhibition of metastasis of murine malignant melanoma by synthetic polimeric peptides containing core sequences of cell-adhesive molecules. Cancer Res 1989; 49: 3815-22.
73. Murata J, Saiki I. Inhibition of tumor metastasis by synthetic peptides analogues of cell adhesive RGD sequence of fibronectin. Nippon Rinsho 1995; 53: 1653-9.
74. Kumagai H, Tajima M, Ueno Y, Giga-Hama Y, Ohba M. Effect of cyclic RGD peptide on cell adhesion and tumor metastasis. Biochem Biophys Res Commun 1991; 177: 74-82.
75. Hardan I, Weiss L, Hershkovis R, Greenspoon N, Alon R, Cahalon L et al. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic Arg-Cly-Asp mimetics. Int J Cancer 1993; 55: 1023-8.
76. Chiang HS, Yang RS, HuangTF. Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta3 integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin. Br J Cancer 1996; 73: 902-8.
77. Beviglia L, Stewart GJ, Niewiaroski S. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncol Res 1995; 7: 7-20.
78. Soska T, Knudsen KA, Beviglia L, Rossi C, Poggi A, Niewiarowski S. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by alborabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp Cell Res 1991; 196: 6-12.
79. Morris VL, Schmidt EE, Koop S, MacDonald IC, Grattan, Khokha R et al. Effect of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp Cell Res 1995; 219: 571-8.
80. Danen EH, Marcinkiewicz C, Cornelissen IM, van Kraats AA, Patcher JA, Ruiter DJ et al. The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cell. Exp Cell Res 1998; 238: 188-96.
81. Pasqualini R, Koivunen E, Ruoslahti E. αv integrins as receptors for tumor targeting by circulanding ligands. Nature Biotech 1997;15: 542-6.
82. Pullman WE, Bodmer WF. Cloning and characterization of a gene that regulates cell adhesion. Nature 1992; 356: 529-32.
83. Yamamoto H, Itho F, Hinoda Y, Imai K. Inverse association of cell adhesion regulator messenger RNA expression with metastasis in human colorectal cancer. Cancer Res 1996; 56: 3605-9.
84. Yamamoto H, Itho F, Sakamoto H, Nakajima Y, Hinoda Y, Imai K. Association of reduced cell adhesion regulator messenger RNA expression with tumor progression in human hepatocellular carcinoma. Int J Cancer 1997; 73: 241-54.
85. Lauer JL, Furcht LT, Fields GB. Inhibition of melanoma cell binding to type IV collagen by analogs of cell adhesion regulator. J Med Chem 1997; 40: 3077-84.
86. Taylor DB, Gartner. A peptide corresponding to CPIIb alpha 300-312, a presumptive fibrinogen gamma-chain binding site on the platelet integrin CpIIb/IIIa, inhibits the adhesion of platelets to at least four adhesive ligands. J Biol Chem 1992; 267: 11729-33.
87. Sanchez-Mateos P, Cabañas C, Sanchez-Madrid F. Regulation of integrin function. Sem Cancer Biol 1996; 7: 99-109.